VPT — VentriPoint Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.62m
- CA$18.91m
- CA$0.18m
Annual cashflow statement for VentriPoint Diagnostics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.88 | -4.87 | -4.87 | -4.92 | -3.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.15 | 1.02 | 0.549 | 0.855 | 0.551 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.463 | -0.331 | 0.452 | 0.699 | 1.09 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.15 | -4.14 | -3.8 | -3.39 | -1.55 |
| Capital Expenditures | -0.004 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.004 | 0 | — | — | — |
| Financing Cash Flow Items | -0.751 | 0 | — | -0.174 | -0.136 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.9 | 0.088 | -0.102 | 2.2 | 1.53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.74 | -4.08 | -3.89 | -1.23 | -0.005 |